The transfer of Procter & Gamble’s European Tissue operations to SCA was completed today. The total purchase price is approximately EUR 512 million, and the first payment of EUR 329 million was made in cash in connection with the closure.
The remaining part of the purchase price, EUR 183 million, will be paid following agreed technical adjustments at certain plants, which are expected to be completed during the first half of 2008.
The acquisition gives SCA key prerequisites for the creation of an even better platform for consumer-driven awareness and will strengthen our market positions in several important markets. The acquisition was described earlier in press releases dated 12 March and 5 September 2007. These can be accessed at www.sca.com.
Stockholm, 1 October 2007
For further information please contact
Bodil Eriksson, SVP Corporate Communications, +46 8 788 52 34
Pär Altan, VP Media Relations, +46 8 788 52 37
This information is such that SCA must disclose in accordance with the Securities and Clearing Operations Act. The information was submitted for publication on 1 October 2007